Efficacy and safety of endostar in the treatment of advanced lung squamous cell carcinoma.

被引：0
|
作者：
Hu, Weiheng
Fang, Jian
Nie, Jun
Dai, Ling
Zhang, Jie
Chen, Xiaoling
Ma, Xiangjuan
Tan, Guangming
Wu, Di
Han, Jindi
Han, Sen
Wang, Yang
Long, Jieran
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e20574
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20574
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Efficacy of chemoradiotherapy for the treatment of locally advanced squamous cell carcinoma of the rectum
    Tronconi, M. C.
    Doci, R.
    Bignardi, M.
    Sclafani, F.
    Personeni, N.
    Bozzarelli, S.
    Rimassa, L.
    Di Rocco, M.
    Santoro, A.
    Carnaghi, C.
    EJC SUPPLEMENTS, 2009, 7 (02): : 327 - 328
  • [32] EFFICACY OF CHEMORADIOTHERAPY FOR THE TREATMENT OF LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE RECTUM
    Tronconi, Maria Chiara
    Doci, Roberto
    Bignardi, Mario
    Sclafani, Francesco
    Bozzarelli, Silvia
    Personeni, Nicola
    Pressiani, Tiziana
    Rimassa, Lorenza
    Di Rocco, Mariagrazia
    Santoro, Armando
    Carnaghi, Carlo
    ANNALS OF ONCOLOGY, 2009, 20
  • [33] Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan
    Senoo, Satoru
    Ninomiya, Kiichiro
    Hotta, Katsuyuki
    Kiura, Katsuyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (05) : 461 - 467
  • [34] Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan
    Satoru Senoo
    Kiichiro Ninomiya
    Katsuyuki Hotta
    Katsuyuki Kiura
    International Journal of Clinical Oncology, 2019, 24 : 461 - 467
  • [35] Factors related to advanced stage oral squamous cell carcinoma.
    Kerdpon, D
    Sriplung, H
    JOURNAL OF DENTAL RESEARCH, 2000, 79 : 238 - 238
  • [36] Efficacy of dendritic cell infusion in advanced hepatocellular carcinoma.
    Di, L
    Ren, J
    Song, G
    Yu, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 349S - 349S
  • [37] Comparison of efficacy and safety of salvage-line nivolumab monotherapy between 240 and 480 mg for advanced esophageal squamous cell carcinoma.
    Murashima, Yuko
    Yamamoto, Shun
    Hirose, Toshiharu
    Kadono, Toru
    Ikeda, Go
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Ishiyama, Koshiro
    Oguma, Junya
    Daiko, Hiroyuki
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 317 - 317
  • [38] Efficacy and safety of apatinib with or without radiotherapy as second-line or beyond therapy in patients with advanced/recurrent esophageal squamous cell carcinoma.
    Lv, Jiahua
    Li, Tao
    Wang, Qifeng
    Fan, Yu
    Wang, Junchao
    Lang, Jinyi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] A Prospective Clinical Study On The Efficacy And Safety Of Anlotinib In The Treatment Of Recurrent / Metastatic Advanced Esophageal Squamous Cell Carcinoma
    Li, K.
    Li, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E609 - E609
  • [40] Efficacy and safety of liposome-paclitaxel and carboplatin based concurrent chemoradiotherapy for locally advanced lung squamous cell carcinoma
    Chen, Guofu
    Sheng, Liming
    Du, Xianghui
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (03) : 505 - 510
12345